Hemophagocytic Macrophages and Systemic Salmonella Infection

噬血细胞巨噬细胞和全身性沙门氏菌感染

基本信息

  • 批准号:
    8292621
  • 负责人:
  • 金额:
    $ 18.54万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-03-01 至 2017-02-28
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Many bacterial pathogens important to human health evade the immune system by living within white blood cells. Salmonella enterica, a species of gram-negative bacteria that includes the causative agent of human typhoid fever, resides within a class of white blood cells called macrophages. We have demonstrated that in mice, S. enterica subspecies Typhimurium (Salmonella) resides and replicates within hemophagocytic macrophages (HM¿), which are macrophages that have engulfed erythrocytes, platelets, leukocytes and their precursor cells. Our long-term goal is to determine how Salmonella and HM¿s interact to cause disease. Mice infected with Salmonella are a natural host-pathogen model system encountered in the wild. Salmonella causes an acute infection in mice that typically resolves into a chronic infection, and the disease course resembles that of typhoid fever. The bacteria colonize the spleen, liver, and the lymph nodes that drain the intestine. We demonstrated the presence of HM¿s within the spleen, liver and bone marrow of Salmonella - infected mice and identified HM¿s containing Salmonella as late as eight weeks post-infection in the liver, when persistent infection has been established. In Preliminary Studies we developed a flow cytometric assay to identify and separate HM¿s from the spleen. This novel methodology along with established approaches enables new exploration of the role of HM¿s in disease. The objectives of the current application are to 1) Determine the immunological requirements for hemophagocytosis and the effect of HM¿ accumulation on the course of murine typhoid fever, 2) Establish whether HM¿s formed in response to Salmonella infection in vivo or in culture become anti-inflammatory and whether anti-inflammatory macrophages are permissive for bacterial replication, and 3) Identify regulatory pathways within HM¿s needed to make them permissive for Salmonella replication. Completion of these Aims has the potential to elucidate whether hemophagocytosis benefits the host as well as Salmonella. In addition, the information we acquire has potential use in the development of treatments that modulate hemophagocytosis and influence the course of inflammation in infectious and non-infectious circumstances. PUBLIC HEALTH RELEVANCE: The work proposed within has the potential to define novel and important mechanisms of host-pathogen interactions not only for Salmonella, but by inference for other microbes that trigger HM¿ accumulation, including Mycobacterium tuberculosis, Leishmania species, and Histoplasma capsulatum. The long-term significance of the proposed work is its potential to suggest novel therapeutic approaches to infectious and non-infectious diseases in which HM¿s accumulate.
描述(适用提供):许多对人类健康重要的细菌病原体通过生活在白细胞中逃避免疫学系统。沙门氏菌Enterica是一种革兰氏阴性细菌,其中包括人伤寒的属属,位于一类称为巨噬细胞的白细胞中。我们已经证明,在小鼠中,肠道葡萄球菌(沙门氏菌)居住并重复在血型巨噬细胞中(HM¿),这些巨噬细胞吞噬了红细胞,血platelets,platelets,platelets,platelets,leukocytes及其前体细胞。我们的长期目标是确定沙门氏菌和HMS如何相互作用以引起疾病。感染沙门氏菌的小鼠是野外遇到的天然宿主 - 病原体模型系统。沙门氏菌会引起通常溶解成慢性感染的小鼠急性感染,并且疾病病程类似于伤寒。细菌定居脾脏,肝脏和耗尽肠道的淋巴结。我们证明了沙门氏菌感染的小鼠的囊,肝脏和骨髓中的HMS存在,并在肝脏感染后八周内确定了HM?s含有沙门氏菌,并确定了持续性感染。在初步研究中,我们开发了一种流式细胞术测定,以识别并将HM与脾脏分离。这种新颖的方法以及既定的方法可以使人们对HM在疾病中的作用进行新的探索。 The objects of the current application are to 1) Determine the immunological requirements for hemophagocytosis and the effect of HM¿ Accumulation on the course of murine typhoid fever, 2) Establish whether HM¿ s formed in response to Salmonella infection in vivo or in culture become anti-inflammatory and whether anti-inflammatory macrophages are permissive for bacteria replication, and 3) Identify regulatory pathways within HM¿ s needed to使它们允许沙门氏菌复制。这些目标的完成有可能阐明胞吞作用是否使宿主和沙门氏菌受益。此外,我们获取的信息在调节胞吞作用并影响传染性和非感染情况的炎症过程的治疗过程中可能使用。 公共卫生相关性:内部提出的工作具有定义宿主 - 病原体相互作用的新颖和重要机制的潜力,不仅是沙门氏菌的,而且还通过推断其他触发HM累积的微生物,包括结核分枝杆菌,利什曼原虫物种和组织囊肿。拟议工作的长期意义在于它的潜力是提出新型的治疗方法,以促进HM?S积累的传染病和非感染疾病。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(2)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Corrella S Detweiler其他文献

Corrella S Detweiler的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Corrella S Detweiler', 18)}}的其他基金

Using Salmonella Pathogenesis and Cell Biology as a Discovery Tool
使用沙门氏菌发病机制和细胞生物学作为发现工具
  • 批准号:
    10665946
  • 财政年份:
    2023
  • 资助金额:
    $ 18.54万
  • 项目类别:
Infection-Dependent Vulnerabilities of Gram-negative Bacterial Pathogens
革兰氏阴性细菌病原体的感染依赖性脆弱性
  • 批准号:
    10592676
  • 财政年份:
    2023
  • 资助金额:
    $ 18.54万
  • 项目类别:
A Small Molecule That Blocks Salmonella Replication in Macrophages
阻止沙门氏菌在巨噬细胞中复制的小分子
  • 批准号:
    10312125
  • 财政年份:
    2020
  • 资助金额:
    $ 18.54万
  • 项目类别:
Chemical Probes for Bacteria-Macrophage Interactions
用于细菌-巨噬细胞相互作用的化学探针
  • 批准号:
    9171993
  • 财政年份:
    2016
  • 资助金额:
    $ 18.54万
  • 项目类别:
Macrophages, Granulomas, and Bacterial Persistence
巨噬细胞、肉芽肿和细菌持久性
  • 批准号:
    9277403
  • 财政年份:
    2016
  • 资助金额:
    $ 18.54万
  • 项目类别:
A Novel Screen for Antibacterials that Are Non-Toxic to Mammals
一种对哺乳动物无毒的抗菌药物的新型筛选
  • 批准号:
    9186486
  • 财政年份:
    2015
  • 资助金额:
    $ 18.54万
  • 项目类别:
A Novel Screen for Antibacterials that Are Non-Toxic to Mammals
一种对哺乳动物无毒的抗菌药物的新型筛选
  • 批准号:
    9015218
  • 财政年份:
    2015
  • 资助金额:
    $ 18.54万
  • 项目类别:
Host Pathways that Enable /Salmonella/ Replication Within Hemophagocytic Macropha
使/沙门氏菌/在噬血细胞巨噬细胞内复制的宿主途径
  • 批准号:
    8281809
  • 财政年份:
    2012
  • 资助金额:
    $ 18.54万
  • 项目类别:
Host Pathways that Enable /Salmonella/ Replication Within Hemophagocytic Macropha
使/沙门氏菌/在噬血细胞巨噬细胞内复制的宿主途径
  • 批准号:
    8418684
  • 财政年份:
    2012
  • 资助金额:
    $ 18.54万
  • 项目类别:
Hemophagocytic Macrophages and Systemic Salmonella Infection
噬血细胞巨噬细胞和全身性沙门氏菌感染
  • 批准号:
    8805824
  • 财政年份:
    2012
  • 资助金额:
    $ 18.54万
  • 项目类别:

相似国自然基金

阿魏酸基天然抗氧化抗炎纳米药物用于急性肾损伤诊疗一体化研究
  • 批准号:
    82302281
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
SGO2/MAD2互作调控肝祖细胞的细胞周期再进入影响急性肝衰竭肝再生的机制研究
  • 批准号:
    82300697
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
基于hemin-MOFs的急性心肌梗塞标志物负背景光电化学-比色双模分析
  • 批准号:
    22304039
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
RNA甲基转移酶NSUN2介导SCD1 mRNA m5C修饰调控急性髓系白血病细胞铁死亡的机制研究
  • 批准号:
    82300173
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
基于IRF5/MYD88信号通路调控巨噬细胞M1极化探讨针刀刺营治疗急性扁桃体炎的机制研究
  • 批准号:
    82360957
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    地区科学基金项目

相似海外基金

Microglial process convergence following brain injury
脑损伤后小胶质细胞过程收敛
  • 批准号:
    10657968
  • 财政年份:
    2023
  • 资助金额:
    $ 18.54万
  • 项目类别:
A decellularized porcine placenta matrix hydrogel for management of radiation-induced proctitis
用于治疗放射性直肠炎的脱细胞猪胎盘基质水凝胶
  • 批准号:
    10599727
  • 财政年份:
    2023
  • 资助金额:
    $ 18.54万
  • 项目类别:
Biomimetic Macrophage Membrane-Coated Nanosponges: A Novel Therapeutic for Multidrug-Resistant Pseudomonas aeruginosa and Acinetobacter baumannii Hospital-Associated Pneumonia
仿生巨噬细胞膜包被的纳米海绵:一种治疗多重耐药铜绿假单胞菌和鲍曼不动杆菌医院相关肺炎的新疗法
  • 批准号:
    10674406
  • 财政年份:
    2023
  • 资助金额:
    $ 18.54万
  • 项目类别:
Endothelial Cell Respiration in Atherosclerotic Plaque Erosion
动脉粥样硬化斑块糜烂中的内皮细胞呼吸
  • 批准号:
    10586227
  • 财政年份:
    2023
  • 资助金额:
    $ 18.54万
  • 项目类别:
Role of extracellular vesicles in assaying and regulating immune dysfunction after burn injury
细胞外囊泡在测定和调节烧伤后免疫功能障碍中的作用
  • 批准号:
    10607063
  • 财政年份:
    2023
  • 资助金额:
    $ 18.54万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了